Product NDC: | 60760-175 |
Proprietary Name: | GLIPIZIDE and METFORMIN HYDROCHLORIDE |
Non Proprietary Name: | GLIPIZIDE and METFORMIN HYDROCHLORIDE |
Active Ingredient(s): | 2.5; 500 mg/1; mg/1 & nbsp; GLIPIZIDE and METFORMIN HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60760-175 |
Labeler Name: | St Marys Medical Park Pharmacy |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077270 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130509 |
Package NDC: | 60760-175-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-175-30) |
NDC Code | 60760-175-30 |
Proprietary Name | GLIPIZIDE and METFORMIN HYDROCHLORIDE |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-175-30) |
Product NDC | 60760-175 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | GLIPIZIDE and METFORMIN HYDROCHLORIDE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130509 |
Marketing Category Name | ANDA |
Labeler Name | St Marys Medical Park Pharmacy |
Substance Name | GLIPIZIDE; METFORMIN HYDROCHLORIDE |
Strength Number | 2.5; 500 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient],Biguanide [EPC],Biguanides [Chemical/Ingredient] |